IL-4, IL-13, and IL-5 production has been demonstrated to induce clinical symptoms of asthma, including eosinophilia (33) and airway hypersensitivity (34), indicating a clear role for ST2+ CXCR6+ Th2 cells in driving acute allergic disease. Here, CXCR6 is linked to Increased total eosinophil count.